Your browser doesn't support javascript.
loading
Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.
Htoo, Phyo T; Tesfaye, Helen; Schneeweiss, Sebastian; Wexler, Deborah J; Everett, Brendan M; Glynn, Robert J; Kim, Seoyoung C; Najafzadeh, Mehdi; Koeneman, Lisette; Farsani, Soulmaz Fazeli; Déruaz-Luyet, Anouk; Paik, Julie M; Patorno, Elisabetta.
Afiliación
  • Htoo PT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Tesfaye H; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Wexler DJ; Massachusetts General Hospital Diabetes Center, Harvard Medical School, Boston, Massachusetts.
  • Everett BM; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Glynn RJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Kim SC; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Najafzadeh M; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Koeneman L; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Farsani SF; Global Medical Affairs, Lilly Deutschland, Aalen, Germany.
  • Déruaz-Luyet A; Global Epidemiology, Boehringer Ingelheim International, Ingelheim am Rheim, Germany.
  • Paik JM; Global Epidemiology, Boehringer Ingelheim International, Ingelheim am Rheim, Germany.
  • Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
JAMA Netw Open ; 5(10): e2237606, 2022 10 03.
Article en En | MEDLINE | ID: mdl-36264574
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_chronic_kidney_disease / 6_endocrine_disorders / 6_ischemic_heart_disease / 6_other_circulatory_diseases Asunto principal: Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica / Aterosclerosis / Insuficiencia Cardíaca / Infarto del Miocardio Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: JAMA Netw Open Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_chronic_kidney_disease / 6_endocrine_disorders / 6_ischemic_heart_disease / 6_other_circulatory_diseases Asunto principal: Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica / Aterosclerosis / Insuficiencia Cardíaca / Infarto del Miocardio Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: JAMA Netw Open Año: 2022 Tipo del documento: Article